Literature DB >> 10780242

Subjective and behavioral effects of repeated d-amphetamine in humans.

S R Wachtel1, H de Wit.   

Abstract

Behavioral sensitization is thought to be an important determinant of drug-taking and drug-seeking behaviors. Although there is abundant research characterizing behavioral sensitization in animals, there is little evidence for this phenomenon in humans. The aim of the present study was to determine if repeated oral d-amphetamine administration enhances self-reported mood and other behavioral indices of d-amphetamine effects in humans. Sixteen healthy volunteers, with no prior stimulant use, received two doses of d-amphetamine (20 mg) and two doses of placebo, in alternating order, on 4 consecutive days, under double-blind conditions. Mood and behavioral effects were measured using standard self-report questionnaires. Heart rate, blood pressure, psychomotor performance, and tapping speed were also monitored. d-Amphetamine elicited prototypical increases on several measures including self-reported drug effects, mood, and physiological responses. However, except for a slight reduction in 'feel drug' scores during the first hour of the second d-amphetamine session, the majority of effects were not altered on the second session. These results indicate that the subjective effects of d-amphetamine display only an apparent mild tolerance after a single exposure 48 h earlier.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780242     DOI: 10.1097/00008877-199905000-00004

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  16 in total

1.  Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.

Authors:  Thomas H Kelly; Glenn Robbins; Catherine A Martin; Mark T Fillmore; Scott D Lane; Nancy G Harrington; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

2.  The effects of dexamphetamine on simulated driving performance.

Authors:  B Y Silber; K Papafotiou; R J Croft; E Ogden; P Swann; C Stough
Journal:  Psychopharmacology (Berl)       Date:  2004-12-22       Impact factor: 4.530

Review 3.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

4.  Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Xavier Castells; Lídia Blanco-Silvente; Ruth Cunill
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

5.  Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects.

Authors:  Patrick C Dolder; Petra Strajhar; Patrick Vizeli; Alex Odermatt; Matthias E Liechti
Journal:  Psychopharmacology (Berl)       Date:  2018-02-09       Impact factor: 4.530

6.  Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.

Authors:  Tara L White; Mollie A Monnig; Edward G Walsh; Adam Z Nitenson; Ashley D Harris; Ronald A Cohen; Eric C Porges; Adam J Woods; Damon G Lamb; Chelsea A Boyd; Sinda Fekir
Journal:  Neuropsychopharmacology       Date:  2018-03-06       Impact factor: 7.853

7.  The influence of amphetamine on language activation: an fMRI study.

Authors:  Iris E C Sommer; Bob Oranje; Nick F Ramsey; Floris A Klerk; René C W Mandl; Herman G M Westenberg; René S Kahn
Journal:  Psychopharmacology (Berl)       Date:  2005-11-12       Impact factor: 4.530

Review 8.  Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction.

Authors:  Charles W Bradberry
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

Review 9.  Striatal ups and downs: their roles in vulnerability to addictions in humans.

Authors:  Marco Leyton; Paul Vezina
Journal:  Neurosci Biobehav Rev       Date:  2013-01-16       Impact factor: 8.989

Review 10.  The use of neuroproteomics in drug abuse research.

Authors:  Melinda E Lull; Willard M Freeman; Heather D VanGuilder; Kent E Vrana
Journal:  Drug Alcohol Depend       Date:  2009-11-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.